policy+practice

Medical schemes, funds that pool member contributions to cover healthcare costs, have been in talks with the government over funding vaccines for those without access to private health cover as well as their own members.

The main reason for delays and extensions is that sponsors submit their applications too soon.

Commission president responds to fresh criticism over shortages of vaccine doses in bloc.

A new systematic review analyzing drug pricing policies in sub-Saharan Africa.

Professor David Ridley will share insights from his new research that suggests that the way Medicare​ pays health care providers for drugs inadvertently encourages drug makers to charge higher prices.

How can pharmaceutical companies successfully apply advanced analytics?

For the past several years, the price of pharmaceuticals has been an important federal policy issue and the debate has featured a variety of proposals, some of which are incredibly dangerous and counterproductive.

In the case of one country, demands made by the pharmaceutical giant led to a three-month delay in a vaccine deal being agreed.

Boris Johnson has said that the UK government is considering whether to introduce so-called “vaccine passports”.

Prime Minister Boris Johnson has tasked Michael Gove with leading a review into the possible use of vaccine certificates - or domestic vaccine passports - for businesses in the UK.

The attack on Xavier Becerra, California’s attorney general, is a surprising twist following years of agitation on Capitol Hill and from the Trump administration over high drug prices.

Colombia has secured vaccine agreements with a raft of pharmaceutical companies and the World Health Organization-backed COVAX program.

VICE News talks to an emergency room physician about why Black and brown communities are being left behind in the vaccine rollout.

India, the world’s biggest maker of vaccines, has shipped over 17 million vaccine doses to more than two dozen countries - including around 6 million as gifts to partners such as Bangladesh and Nepal.

Becerra fields questions on drug pricing during his HELP Committee confirmation hearing.